ETFMG Treatments Testing and Advancements ETF

ETFMG Treatments Testing and Advancements ETF (GERM)

Description

The investment seeks to track the performance of the Prime Treatments, Testing and Advancements Index. The GERM ETF contains 80 constituents. It is focused on blend holdings in the North America region.

Price $20.64 as of 2022-10-20

Cost/Risk/Yield

Dividend yield	0.54%
Expense ratio	0.68%
Average spread	0.775%
1Y roundtrip cost	1.455%

Historic prices

Total Returns (including dividends)

Returns by Year

Returns by Period

Monthly returns heatmap

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2022	-21.4%	-1.9%	-0.4%	-15.2%	0.7%	-0.3%	7.2%	-6.0%	-11.4%	-0.4%			-49.0%
2021	26.6%	-2.4%	-7.7%	7.2%	-0.8%	6.3%	2.6%	7.2%	-6.7%	-7.6%	5.4%	-10.8%	19.2%
2020							11.5%	-13.9%	0.8%	-1.5%	22.2%	-5.7%	13.5%
	5.2%	-4.2%	-8.1%	-8.0%	-0.1%	6.0%	21.4%	-12.7%	-17.2%	-9.6%	27.5%	-16.5%

Historical Dividends

Dividends by Year

Dividend Yields by Year

Monthly dividend heatmap

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2022						0.05			0.06				0.11
2021						0.06			0.04			0.00	0.10
2020												0.28	0.28
	0.00	0.00	0.00	0.00	0.00	0.11	0.00	0.00	0.10	0.00	0.00	0.29

Sectors and Top Holdings

Security	% Assets
Laboratory Corporation of America Holdings	6.70%
Moderna, Inc.	6.25%
BioNTech SE Sponsored ADR	6.10%
Alnylam Pharmaceuticals, Inc	5.73%
Bio-Rad Laboratories, Inc. Class A	4.62%
Quest Diagnostics Incorporated	4.54%
Novavax, Inc.	4.13%
Quidel Corporation	3.44%
Zai Lab Ltd. Sponsored ADR	3.43%
Vir Biotechnology, Inc.	3.07%
Adaptive Biotechnologies Corp.	2.93%
Ortho Clinical Diagnostics Holdings Plc	2.89%
I-MAB Sponsored ADR	2.79%
AbCellera Biologics, Inc.	2.72%
CureVac N.V.	2.68%
Top 15 Weights	62.02%

Compare with similar ETFs

	GERM	IBB	IBBQ	IDNA	IEIH	PBE
Product name	ETFMG Treatments Testing and Advancements ETF	iShares Nasdaq Biotechnology ETF	Invesco Nasdaq Biotechnology ETF	iShares Genomics Immunology and Healthcare ETF	iShares Evolved U.S. Innovative Healthcare ETF	PowerShares Dynamic Biotechnology & Genome Portfolio ETF
Issuer	ETF Managers Group	iShares	Invesco	iShares	iShares	Invesco
Price	$20.64	$117.58	$18.95	$26.91	$34.1348	$59.39
Expense Ratio	0.68%	0.45%	0%	0.47%	0.18%	0.59%
Average Spread	0.775%	0.017%	0.211%	0.223%	0.146%	0.253%
AUM	$30,340,400	$7,490,990,000	$33,791,400	$184,587,000	$40,743,700	$226,683,000
Shares	1,469,979	63,709,707	1,783,189	6,859,406	1,193,612	3,816,854
Average Daily Volume	2,471	1,968,141	8,192	54,549	2,776	8,743
Home page	Visit external site	Visit external site	Visit external site	Visit external site	Visit external site	Visit external site
Inception Date	2020-06-17	2001-02-05	2021-06-11	2019-06-11	2018-03-21	2005-06-23
Index Tracked	Prime Treatments, Testing and Advancements Index	ICE Biotechnology Index	NASDAQ Biotechnology Index	NYSE FactSet Global Genomics and Immuno Biopharma Index	No Underlying Index	Dynamic Biotechnology & Genome Intellidex Index
Category	All Cap Equities	Health & Biotech Equities	n/a	Health & Biotech Equities	Health & Biotech Equities	Health & Biotech Equities
Asset Class	Equity	Equity	Equity	Equity	Equity	Equity
Asset Class Size	Large/Mid/Small Caps	Large/Mid Caps	Large/Mid Caps	Large/Mid/Small Caps	Large/Mid Caps	Large/Mid/Small Caps
Value or Growth	Blend	Growth		Blend	Growth	Growth
Region	North America	North America	North America	North America	North America	North America
Countries	U.S.	U.S.	U.S.	U.S.	U.S.	U.S.
Annual Dividend Rate	$0.111	$0.349	$0.224	$0.392	$0	$0
Annual Dividend Yield	0.005%	0.003%	0.012%	0.015%	0.000%	0.000%
Number of Holdings	80	267	268	48	247	30
YTD Return	-41.78%	-22.76%	-19.61%	-38.29%	-3.74%	-16.60%
Beta	0.94	1.25	0.95	0.93	0.88	1.22
Upside Beta	-0.20	0.31	-1.23	0.15	0.55	0.12
Downside Beta	-1.37	0.31	-1.22	-0.26	0.59	0.09
Volatility 1Y	37.84%	28.90%	28.75%	37.65%	18.00%	30.04%
Sharpe Ratio 3Y	0.00	0.20	0.00	0.12	0.95	0.31
Treynor Ratio 3Y	0.00	0.00	0.00	0.00	0.01	0.00

Securities Database